(2S,4R)-1-[(2R)-2-[3-[4-[[4-[3-[(3R)-3-[4-[3-amino-6-(2-hydroxyphenyl)-1,2-dihydropyridazin-4-yl]pyrazol-1-yl]but-1-ynyl]cyclobutyl]oxypiperidin-1-yl]methyl]piperidin-1-yl]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-(4-cyanophenyl)ethyl]-4-hydroxypyrrolidine-2-carboxamide

C54H67N11O6 — CID 146340198

IUPAC(2S,4R)-1-[(2R)-2-[3-[4-[[4-[3-[(3R)-3-[4-[3-amino-6-(2-hydroxyphenyl)-1,2-dihydropyridazin-4-yl]pyrazol-1-yl]but-1-ynyl]cyclobutyl]oxypiperidin-1-yl]methyl]piperidin-1-yl]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-(4-cyanophenyl)ethyl]-4-hydroxypyrrolidine-2-carboxamide
SMILESCC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)c1ccc(C#N)cc1)c1cc(N2CCC(CN3CCC(OC4CC(C#C[C@@H](C)n5cc(C6=C(N)NNC(c7ccccc7O)=C6)cn5)C4)CC3)CC2)no1
InChIInChI=1S/C54H67N11O6/c1-33(2)51(54(69)64-32-41(66)25-47(64)53(68)58-35(4)39-13-11-36(28-55)12-14-39)49-27-50(61-71-49)63-21-15-37(16-22-63)30-62-19-17-42(18-20-62)70-43-23-38(24-43)10-9-34(3)65-31-40(29-57-65)45-26-46(59-60-52(45)56)44-7-5-6-8-48(44)67/h5-8,11-14,26-27,29,31,33-35,37-38,41-43,47,51,59-60,66-67H,15-25,30,32,56H2,1-4H3,(H,58,68)/t34-,35+,38?,41-,43?,47+,51-/m1/s1
InChIKeyNHTLLVUVXZTVJO-IYLQXULBSA-N
MW966.20 g/mol
LogP5.54
Rot. Bonds14

About (2S,4R)-1-[(2R)-2-[3-[4-[[4-[3-[(3R)-3-[4-[3-amino-6-(2-hydroxyphenyl)-1,2-dihydropyridazin-4-yl]pyrazol-1-yl]but-1-ynyl]cyclobutyl]oxypiperidin-1-yl]methyl]piperidin-1-yl]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-(4-cyanophenyl)ethyl]-4-hydroxypyrrolidine-2-carboxamide

(2S,4R)-1-[(2R)-2-[3-[4-[[4-[3-[(3R)-3-[4-[3-amino-6-(2-hydroxyphenyl)-1,2-dihydropyridazin-4-yl]pyrazol-1-yl]but-1-ynyl]cyclobutyl]oxypiperidin-1-yl]methyl]piperidin-1-yl]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-(4-cyanophenyl)ethyl]-4-hydroxypyrrolidine-2-carboxamide (PubChem CID 146340198) has the molecular formula C54H67N11O6 and a molecular weight of 966.20 g/mol. Its IUPAC name is (2S,4R)-1-[(2R)-2-[3-[4-[[4-[3-[(3R)-3-[4-[3-amino-6-(2-hydroxyphenyl)-1,2-dihydropyridazin-4-yl]pyrazol-1-yl]but-1-ynyl]cyclobutyl]oxypiperidin-1-yl]methyl]piperidin-1-yl]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-(4-cyanophenyl)ethyl]-4-hydroxypyrrolidine-2-carboxamide.

Molecular Properties

Compound Name(2S,4R)-1-[(2R)-2-[3-[4-[[4-[3-[(3R)-3-[4-[3-amino-6-(2-hydroxyphenyl)-1,2-dihydropyridazin-4-yl]pyrazol-1-yl]but-1-ynyl]cyclobutyl]oxypiperidin-1-yl]methyl]piperidin-1-yl]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-(4-cyanophenyl)ethyl]-4-hydroxypyrrolidine-2-carboxamide
PubChem CID146340198
Molecular FormulaC54H67N11O6
Molecular Weight966.20 g/mol
Exact Mass965.53
IUPAC Name(2S,4R)-1-[(2R)-2-[3-[4-[[4-[3-[(3R)-3-[4-[3-amino-6-(2-hydroxyphenyl)-1,2-dihydropyridazin-4-yl]pyrazol-1-yl]but-1-ynyl]cyclobutyl]oxypiperidin-1-yl]methyl]piperidin-1-yl]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-(4-cyanophenyl)ethyl]-4-hydroxypyrrolidine-2-carboxamide
SMILESCC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)c1ccc(C#N)cc1)c1cc(N2CCC(CN3CCC(OC4CC(C#C[C@@H](C)n5cc(C6=C(N)NNC(c7ccccc7O)=C6)cn5)C4)CC3)CC2)no1
InChIInChI=1S/C54H67N11O6/c1-33(2)51(54(69)64-32-41(66)25-47(64)53(68)58-35(4)39-13-11-36(28-55)12-14-39)49-27-50(61-71-49)63-21-15-37(16-22-63)30-62-19-17-42(18-20-62)70-43-23-38(24-43)10-9-34(3)65-31-40(29-57-65)45-26-46(59-60-52(45)56)44-7-5-6-8-48(44)67/h5-8,11-14,26-27,29,31,33-35,37-38,41-43,47,51,59-60,66-67H,15-25,30,32,56H2,1-4H3,(H,58,68)/t34-,35+,38?,41-,43?,47+,51-/m1/s1
InChIKeyNHTLLVUVXZTVJO-IYLQXULBSA-N
XLogP5.54
TPSA223.30 Ų
H-Bond Donors6
H-Bond Acceptors15
Rotatable Bonds14
Heavy Atoms71
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 500966.20
LogP ≤ 55.54
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze (2S,4R)-1-[(2R)-2-[3-[4-[[4-[3-[(3R)-3-[4-[3-amino-6-(2-hydroxyphenyl)-1,2-dihydropyridazin-4-yl]pyrazol-1-yl]but-1-ynyl]cyclobutyl]oxypiperidin-1-yl]methyl]piperidin-1-yl]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-(4-cyanophenyl)ethyl]-4-hydroxypyrrolidine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S,4R)-1-[(2R)-2-[3-[4-[[4-[3-[(3R)-3-[4-[3-amino-6-(2-hydroxyphenyl)-1,2-dihydropyridazin-4-yl]pyrazol-1-yl]but-1-ynyl]cyclobutyl]oxypiperidin-1-yl]methyl]piperidin-1-yl]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-(4-cyanophenyl)ethyl]-4-hydroxypyrrolidine-2-carboxamide?
The IUPAC name of (2S,4R)-1-[(2R)-2-[3-[4-[[4-[3-[(3R)-3-[4-[3-amino-6-(2-hydroxyphenyl)-1,2-dihydropyridazin-4-yl]pyrazol-1-yl]but-1-ynyl]cyclobutyl]oxypiperidin-1-yl]methyl]piperidin-1-yl]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-(4-cyanophenyl)ethyl]-4-hydroxypyrrolidine-2-carboxamide (CID 146340198) is (2S,4R)-1-[(2R)-2-[3-[4-[[4-[3-[(3R)-3-[4-[3-amino-6-(2-hydroxyphenyl)-1,2-dihydropyridazin-4-yl]pyrazol-1-yl]but-1-ynyl]cyclobutyl]oxypiperidin-1-yl]methyl]piperidin-1-yl]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-(4-cyanophenyl)ethyl]-4-hydroxypyrrolidine-2-carboxamide.
What is the SMILES notation for (2S,4R)-1-[(2R)-2-[3-[4-[[4-[3-[(3R)-3-[4-[3-amino-6-(2-hydroxyphenyl)-1,2-dihydropyridazin-4-yl]pyrazol-1-yl]but-1-ynyl]cyclobutyl]oxypiperidin-1-yl]methyl]piperidin-1-yl]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-(4-cyanophenyl)ethyl]-4-hydroxypyrrolidine-2-carboxamide?
The canonical SMILES for (2S,4R)-1-[(2R)-2-[3-[4-[[4-[3-[(3R)-3-[4-[3-amino-6-(2-hydroxyphenyl)-1,2-dihydropyridazin-4-yl]pyrazol-1-yl]but-1-ynyl]cyclobutyl]oxypiperidin-1-yl]methyl]piperidin-1-yl]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-(4-cyanophenyl)ethyl]-4-hydroxypyrrolidine-2-carboxamide is CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)c1ccc(C#N)cc1)c1cc(N2CCC(CN3CCC(OC4CC(C#C[C@@H](C)n5cc(C6=C(N)NNC(c7ccccc7O)=C6)cn5)C4)CC3)CC2)no1.
What is the InChIKey of (2S,4R)-1-[(2R)-2-[3-[4-[[4-[3-[(3R)-3-[4-[3-amino-6-(2-hydroxyphenyl)-1,2-dihydropyridazin-4-yl]pyrazol-1-yl]but-1-ynyl]cyclobutyl]oxypiperidin-1-yl]methyl]piperidin-1-yl]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-(4-cyanophenyl)ethyl]-4-hydroxypyrrolidine-2-carboxamide?
The InChIKey is NHTLLVUVXZTVJO-IYLQXULBSA-N. The full InChI is InChI=1S/C54H67N11O6/c1-33(2)51(54(69)64-32-41(66)25-47(64)53(68)58-35(4)39-13-11-36(28-55)12-14-39)49-27-50(61-71-49)63-21-15-37(16-22-63)30-62-19-17-42(18-20-62)70-43-23-38(24-43)10-9-34(3)65-31-40(29-57-65)45-26-46(59-60-52(45)56)44-7-5-6-8-48(44)67/h5-8,11-14,26-27,29,31,33-35,37-38,41-43,47,51,59-60,66-67H,15-25,30,32,56H2,1-4H3,(H,58,68)/t34-,35+,38?,41-,43?,47+,51-/m1/s1.
What are the key properties of (2S,4R)-1-[(2R)-2-[3-[4-[[4-[3-[(3R)-3-[4-[3-amino-6-(2-hydroxyphenyl)-1,2-dihydropyridazin-4-yl]pyrazol-1-yl]but-1-ynyl]cyclobutyl]oxypiperidin-1-yl]methyl]piperidin-1-yl]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-(4-cyanophenyl)ethyl]-4-hydroxypyrrolidine-2-carboxamide?
(2S,4R)-1-[(2R)-2-[3-[4-[[4-[3-[(3R)-3-[4-[3-amino-6-(2-hydroxyphenyl)-1,2-dihydropyridazin-4-yl]pyrazol-1-yl]but-1-ynyl]cyclobutyl]oxypiperidin-1-yl]methyl]piperidin-1-yl]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-(4-cyanophenyl)ethyl]-4-hydroxypyrrolidine-2-carboxamide has a molecular weight of 966.20 g/mol, XLogP of 5.54, 14 rotatable bonds, 6 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for (2S,4R)-1-[(2R)-2-[3-[4-[[4-[3-[(3R)-3-[4-[3-amino-6-(2-hydroxyphenyl)-1,2-dihydropyridazin-4-yl]pyrazol-1-yl]but-1-ynyl]cyclobutyl]oxypiperidin-1-yl]methyl]piperidin-1-yl]-1,2-oxazol-5-yl]-3-methylbutanoyl]-N-[(1S)-1-(4-cyanophenyl)ethyl]-4-hydroxypyrrolidine-2-carboxamide is sourced from PubChem (CID 146340198), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).